Galderma Group AG (XSWX:GALD)

Full Year 2024 Galderma Group AG Earnings Call Transcript

Mar 6, 2025 / 01:00 PM GMT

Release Date Price: CHF101.38 (-9.68%)

Transcript

Key Points

Positve

Galderma Group AG (XSWX:GALD) achieved record net sales of $4.4 billion in 2024, marking a 9.3% year-on-year growth at constant currency.
The company set a new profitability record with core EBITDA exceeding $1 billion for the first time, with a margin of 23.4%.
Galderma's injectable aesthetics and dermatological skincare categories delivered particularly strong performance, contributing significantly to overall growth.
The company expanded its sales force by more than 40% compared to 2023, supporting the launch of new products and growth in emerging markets.
Galderma's e-commerce sales grew over 30% year-on-year, with strong digital engagement reaching billions of consumers globally.

Negative

The US market faced challenges with softer consumer demand and increased competitive pricing, particularly affecting filler demand.
Galderma anticipates the biggest adverse P&L impact from investments in Nemolizumab in 2025, which may affect profitability.
The company faces ongoing pricing pressures on gross margin due to a competitive landscape and some softer consumer demand in the US.
There are concerns about the impact of tariffs on the company's manufacturing footprint and potential price increases for aesthetics consumers.
The US mature therapeutic dermatology portfolio experienced a decline, not yet fully offset by new product sales.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

GALD.S - Galderma Group AG
Full Year 2024 Galderma Group AG Earnings Call
Mar 06, 2025 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day and thank you for standing by. Welcome to Calderma's conference call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question and answer session with financial analysts. To ask a question during the session, analysts connected on the teleconference call will need to press 11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press 11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over to Emil Ivanov, head of strategy, Investor Relations and ESG, to introduce the call. Emil, please go ahead.

-------------------------------------

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.